Switch to
View more

Pfizer Ltd

PFIZER
Health CarePharmaceuticals
MidcapWith a market cap of ₹18,810 cr, stock is ranked 221
Low RiskStock is 1.36x as volatile as Nifty
4,111.5512.25 (+0.30%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
MidcapWith a market cap of ₹18,810 cr, stock is ranked 221
Low RiskStock is 1.36x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
30.71
PB RatioPB Ratio
7.86
Dividend YieldDiv. Yield
0.85%
Sector PESector PE
32.92
Sector PBSector PB
4.57
Sector Div YldSctr Div Yld
0.97%

Forecast & RatingsDetailed Forecast 

80%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Pfizer Limited is a pharmaceutical company. The Company has a portfolio of approximately 140 products across over 15 therapeutic areas.

Brands

Pfizer

Pharmaceutical company

Brands

Pfizer

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20192020202120222.252.342.322.670.430.510.500.61
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Loss of share certificate 
Announced OnJun 21, 2022

Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Limited has received requests for issue of duplicate Share Certificate(s) from Shareholder(s) | Download

Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Limited has received requests for issue of duplicate Share Certificate(s) from Shareholder(s) | Download

Related Party Transaction 
Announced OnJun 3, 2022

Pfizer Limited - Disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (¬タリListing Regulations¬タル) | Download

Pfizer Limited - Disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (¬タリListing Regulations¬タル) | Download

Cash Dividend 
Ex. DateAug 11, 2021

Special • Div/Share: ₹ 5

See all events